UW Medicine physician/scientist Danny E. Miller has received a competitive National Institutes of Health Director’s Early Independence Award, a part of the NIH’s High-Risk, High-Reward Research Program for his project titled "Long-Read DNA and RNA Sequencing to Identify Disease-Causing Genetic Variation and Streamline Testing". This award provides up to $1.25 million over 5 years.
The Genomics of Rare Disease hosted by the Wellcome Genome Campus will be held virtually this year on March 28-29, 2022
The meeting will explore how genomic research translates into clinical care and informs our understanding of the biology of rare disease. GREGoR Consortium PI Dr. Jennifer Posey from the Baylor College of Medicine is one of the Scientific Program Committee members for this conference and is happy to answer any questions from Consortium members.
The University of Washington Genetics Analysis Center (GAC), based in the School of Public Health’s Department of Biostatistics, will serve as the Data Coordination Center (DCC) for a new Mendelian Genomics Research Consortium. The consortium seeks to significantly increase the number of known single-gene disorders.
UW Medicine in Seattle will be part of a new National Institutes of Health effort to deploy innovative methods and approaches to find the genetic causes of unsolved Mendelian conditions. These conditions are suspected of being the result of changes or mutation in genes or other genomic differences – that have not yet been discovered.